Evidence map›Paper›PMID 42590188›Full record

ReviewJournal of clinical medicine2026

Clinical Practice Recommendations for Non-Dermatologists on the Diagnostic Suspicion of GPP.

Antonella Di Cesare, Elia Rosi, Annalisa Cavallo, Serena Guiducci, Anna Lucia Marigliano, Simone Vanni, Francesca Prignano

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Antonella Di CesareDermatology Unit, USL Toscana Centro, Ospedale P. Palagi, Viale Michelangelo, 41, 50125 Florence, Italy.
Elia RosiSection of Dermatology, Department of Health Sciences, University of Florence, University of Florence Ospedale P. Palagi, Viale Michelangelo, 41, 50125 Florence, Italy.ORCID 0000-0002-4227-7847
Annalisa CavalloInfectious and Tropical Diseases Unit, AOU Azienda Ospedaliero Universitaria Careggi, 50134 Florence, Italy.
Serena GuiducciDepartment of Experimental and Clinical Medicine, Section of Rheumatology, AOU Careggi, University of Florence, 50134 Florence, Italy.ORCID 0000-0003-2722-6475
Anna Lucia MariglianoPharmaceutical Governance and Appropriateness of Prescription Unit, Drug Department, USL Toscana Centro, 59100 Prato, Italy.ORCID 0009-0007-4748-8954
Simone VanniDepartment of Experimental and Clinical Medicine, High Dependency Unit, Careggi University Hospital, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-1201-5715
Francesca PrignanoDermatology Unit, USL Toscana Centro, Ospedale P. Palagi, Viale Michelangelo, 41, 50125 Florence, Italy.ORCID 0000-0002-5997-2045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generalized pustular psoriasis (GPP) is a rare, potentially life-threatening, chronic cutaneous inflammatory disease characterized by unpredictable, recurrent acute flares of painful sterile pustules on a widespread erythematous background. In addition to cutaneous manifestations, patients may experience fever, pruritus, pain, chills, and general malaise, which may be further complicated by secondary infection, sepsis, and organ failure, thus requiring urgent medical treatment and, in some cases, hospitalization. Prompt therapeutic management of the acute phase is crucial for severe cases, and proactive treatment to prevent flares should always be considered. However, early recognition of acute flares can be challenging due to the low frequency of the disease, the rapid onset of flares, the lack of hematological biomarkers and the absence of standardized diagnostic criteria. Moreover, despite the approval of new targeted therapies, there are still several unmet needs, as these treatments are highly expensive, not always readily available, and may have limited efficacy in patients with advanced or complicated disease. For these reasons, multidisciplinary round-table discussions and shared diagnostic and therapeutic algorithms involving dermatologists, who are responsible for diagnosing and treating GPP, and other medical specialists are desirable to facilitate prompt referral to dermatologists for accurate diagnosis and appropriate treatment. We report the updated literature discussed during a multidisciplinary meeting with the aim of providing practice recommendations for clinicians involved in GPP management.

Indexed as

emergencyflaresGPPpsoriasisspesolimab

Identifiers

PMID42590188
PMCPMC13467243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.